- 专利标题: X-ray psoralen activated cancer therapy (X-PACT)
-
申请号: US16554831申请日: 2019-08-29
-
公开(公告)号: US11305131B2公开(公告)日: 2022-04-19
- 发明人: Mark Oldham , Zakaryae Fathi , Wayne F. Beyer , Frederic A. Bourke, Jr. , Harold Walder , Mark DeWhirst , Neil L. Spector , Paul Yoon , Justus Adamson , David Alcorta , Kim Lyerly , Leihua Liu , Takuya Osada
- 申请人: IMMUNOLIGHT, LLC , DUKE UNIVERSITY
- 申请人地址: US MI Detroit; US NC Durham
- 专利权人: IMMUNOLIGHT, LLC,DUKE UNIVERSITY
- 当前专利权人: IMMUNOLIGHT, LLC,DUKE UNIVERSITY
- 当前专利权人地址: US MI Detroit; US NC Durham
- 代理机构: Oblon, McClelland, Maier & Neustadt, L.L.P.
- 主分类号: A61N5/06
- IPC分类号: A61N5/06 ; A61K41/00 ; A61N5/10 ; A61K31/352
摘要:
A system for treating a diseased site in a human or animal body. The system includes a pharmaceutical carrier including one or more phosphors which are capable of emitting light into the diseased site upon interaction, a photoactivatable drug for intercalating into DNA of cells at the diseased site, one or more devices which infuse the diseased sited with the photoactivatable drug and the pharmaceutical carrier, an x-ray or high energy electron source, and a processor programmed to control a dose of x-rays or electrons to the diseased site for production of light inside the tumor to activate the photoactivatable drug.
公开/授权文献
- US20200009398A1 X-RAY PSORALEN ACTIVATED CANCER THERAPY (X-PACT) 公开/授权日:2020-01-09
信息查询